| Company Name: |
Guangzhou PI PI Biotech Inc
|
| Tel: |
020-81716320 +86-13602409664 |
| Email: |
Sales@pipitech.com |
| Products Intro: |
Product Name:Carfilzomib-d8
CAS:1537187-53-3
Purity:90%+ Package:10mg, 25mg, 50mg, 100mg, Other scale please email Sales@pipitech.com Remarks:(αS)-α-[[2-(4-Morpholinyl)acetyl]amino]benzenebutanoyl-L-leucyl-N-[(1S)-3-methyl-1-[[(2R)-2-methyl-2-oxiranyl]carbonyl]butyl]-L-phenylalaninamide-d8
|
| Company Name: |
Clearsynth Canada Inc.
|
| Tel: |
+1.415.685.4395 |
| Email: |
enquiry@clearsynth.com |
| Products Intro: |
Product Name:Carfilzomib D8
Package:10mg
|
| Company Name: |
ChemeGen(Shanghai) Biotechnology Co.,Ltd.
|
| Tel: |
18818260767 |
| Email: |
sales@chemegen.com |
| Products Intro: |
Product Name:Carfilzomib-d8
CAS:1537187-53-3
Purity:98% Package:10 mg;50 mg;100 mg;500 mg;1 g;5 g;10 g
|
| Company Name: |
Energy Chemical
|
| Tel: |
021-58432009 400-005-6266 |
| Email: |
marketing@energy-chemical.com |
| Products Intro: |
Product Name:Carfilzomib-d8
CAS:1537187-53-3
Purity:NULL Package:100mg;10mg;1mg Remarks:NULL
|
|
| | CarfilzoMib-d8 Basic information |
| Product Name: | CarfilzoMib-d8 | | Synonyms: | CarfilzoMib-d8;[2H8]-Carfilzomib;(S)-4-Methyl-N-((S)-1-(((S)-4-methyl-1-((R)-2-methyloxiran-2-yl)-1-oxopentan-2-yl)amino)-1-oxo-3-phenylpropan-2-yl)-2-((S)-2-(2-(morpholino-d8)acetamido)-4-phenylbutanamido)pentanamide | | CAS: | 1537187-53-3 | | MF: | C40H57N5O7 | | MW: | 719.92 | | EINECS: | | | Product Categories: | | | Mol File: | 1537187-53-3.mol |  |
| | CarfilzoMib-d8 Chemical Properties |
| storage temp. | Store at -20°C | | solubility | DMF: 15 mg/ml,DMSO: 15 mg/ml,Ethanol: 1 mg/ml | | form | A solid | | color | White to off-white |
| | CarfilzoMib-d8 Usage And Synthesis |
| Uses | Carfilzomib-d8, is the labeled analogue of Carfilzomib (C183460), which is a second-generation proteasome inhibitor that is used as a treatment in relapsed and refractory multiple myeloma. | | Uses | CarfilzoMib-d8 is a labeled carfilzomib, intended for use as an internal standard for the quantification of Carfilzomib by GC- or LC-mass spectrometry. |
| | CarfilzoMib-d8 Preparation Products And Raw materials |
|